Although some studies suggest that elevated inflammatory markers are linked to pulmonary, cutaneous, and musculoskeletal manifestations of SSc, the role of ESR and C-reactive protein CRP in assessing disease activity in SSc remains a subject of controversy [189]. The gene discussed is CRP; the disease is systemic sclerosis.